Publications by authors named "Maria G Pilo"

Claim this Profile
C
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, Sara Steinmann, Marcella Sini, Maria G Pilo

J Exp Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, Sara Steinmann, Marcella Sini, Maria G Pilo

J Exp Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
Li Che, Panagiotis Paliogiannis, Antonio Cigliano, Maria G Pilo, Xin Chen

Front Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
Li Che, Wenna Chi, Yu Qiao, Jie Zhang, Xinhua Song, Maria G Pilo

Gut· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma.
Antonio Cigliano, Maria Giulia Pilo, Marta Mela, Silvia Ribback, Frank Dombrowski

Medicina (Kaunas)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
Li Che, Panagiotis Paliogiannis, Antonio Cigliano, Maria G Pilo, Xin Chen

Front Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma.
Silvia Ribback, Li Che, Maria G Pilo, Antonio Cigliano, Gavinella Latte

Cell Cycle· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional role of SGK3 in PI3K/Pten driven liver tumor development.
Hui Cao, Zhong Xu, Jingxiao Wang, Antonio Cigliano, Maria G Pilo

BMC Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma.
Xinhua Song, Xianqiong Liu, Haichuan Wang, Jingxiao Wang, Yu Qiao, Maria G Pilo

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway.
Zhong Xu, Junjie Hu, Hui Cao, Maria G Pilo, Antonio Cigliano

Exp Mol Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice.
Shanshan Zhang, Xinhua Song, Dan Cao, Zhong Xu, Biao Fan, Maria G Pilo

J Hepatol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
Jiaoyuan Jia, Yu Qiao, Maria G Pilo, Antonio Cigliano, Xianqiong Liu

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis.
Antonio Cigliano, Maria G Pilo, Lei Li, Gavinella Latte, Marta Szydlowska

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines and AKT-driven hepatocarcinogenesis in mice.
Antonio Cigliano, Chunmei Wang, Maria G Pilo, Marta Szydlowska, Stefania Brozzetti

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis.
Pin Liu, Mengmeng Ge, Junjie Hu, Xiaolei Li, Li Che, Maria G Pilo

Hepatology· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma.
Li Che, Maria G Pilo, Antonio Cigliano, Gavinella Latte, Maria M Simile

Cell Cycle· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells.
Dan Cao, Xinhua Song, Li Che, Xiaolei Li, Maria G Pilo

Liver Int· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models.
Silvia Ribback, Verena Sailer, Enrico Böhning, Julia Günther, Jaqueline Merz, Maria G Pilo

Int J Mol Sci· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade.
Chunmei Wang, Li Che, Junjie Hu, Shanshan Zhang, Lijie Jiang, Maria G Pilo

Liver Int· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.
Lei Li, Li Che, Kevin M Tharp, Hyo-Min Park, Maria G Pilo

Hepatology· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.
Junjie Hu, Li Che, Lei Li, Maria G Pilo, Antonio Cigliano

Sci Rep· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men.
Silvia Ribback, Antonio Cigliano, Nils Kroeger, Maria G Pilo, Luigi Terracciano

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice.
Chunmei Wang, Antonio Cigliano, Lijie Jiang, Xiaolei Li, Biao Fan, Maria G Pilo

Hepatology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice.
Lei Li, Chunmei Wang, Diego F Calvisi, Matthias Evert, Maria G Pilo

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis